IVIT.F Stock Overview
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Invictus MD Strategies Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -99.00% |
33 Year Change | -100.00% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
IVIT.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 4.2% | 2.0% |
1Y | -99.0% | 13.7% | 32.4% |
Return vs Industry: IVIT.F underperformed the US Pharmaceuticals industry which returned -4.4% over the past year.
Return vs Market: IVIT.F underperformed the US Market which returned 15.2% over the past year.
Price Volatility
IVIT.F volatility | |
---|---|
IVIT.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.7% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.9% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: IVIT.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IVIT.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | Imran Haider | www.invictus-md.com |
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta.
Invictus MD Strategies Corp. Fundamentals Summary
IVIT.F fundamental statistics | |
---|---|
Market cap | US$1.25k |
Earnings (TTM) | -US$25.79m |
Revenue (TTM) | US$5.33m |
0.0x
P/S Ratio0.0x
P/E RatioIs IVIT.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IVIT.F income statement (TTM) | |
---|---|
Revenue | CA$7.03m |
Cost of Revenue | CA$4.56m |
Gross Profit | CA$2.47m |
Other Expenses | CA$36.49m |
Earnings | -CA$34.02m |
Last Reported Earnings
Oct 31, 2019
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did IVIT.F perform over the long term?
See historical performance and comparison